MSH|^~\&|MYIIS|MyStateIIS|MYEHR|Myclinic|20201130020020-0500||RSP^K11^RSP_K11|7731029|P|2.5.1|||NE|NE|||||Z42^CDCPHINVS|A_Clinic^SOME_SYSTEM^^^^X68^AN^^^A_Clinic1234|
MSA|AA|793543||||
QAK|37374859|OK|Z44^Request Evaluated History and Forecast^CDCPHINVS|||
QPD|Z44^Request Evaluated History and Forecast^CDCPHINVS|37374859||Marina^Juan^Marcel^^^^L|Morales^Anita^Francesca^^^^L|201903041100|M|4623 Standish Way^^Stamford^CT^06903^^L|^PRN^CP^^1^203^5551213
PID|1||123456^^^MYEHR^MR~987633^^^MYIIS^SR||Marina^Juan^Marcel^^^^L|Morales^Anita^Francesca^^^^M|201903041100|M||2106-3^White^CDCREC|4623 Standish Way^^Stamford^CT^06903^USA^L||^^^^1^203^5551213||eng^English^ISO639|||||||2135-2^Hispanic or Latino^CDCREC
ORC|RE||197027^SH|||||||^Sirtis^Lisa||^Carter^Jane^^^^^^^L^^^^^^^^^^^MD|||||SH^Shoreline Hospital^HL70362||||||||||||||
RXA|0|1|20190304|20190304|08^Hepatitis B^CVX^58160-0820-43^ENGERIX-B^NDC|0.5|mL^^UCUM||00^^NIP001|^Martinez^J.|^^^SH^^^^^325 Shoreline Drive^^Stamford^CT^06901||||6332FK34|20191214|SKB^GlaxoSmithKline Biologicals SA^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LT^Left Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|45^hepatitis B vaccine, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20190304
OBX|3|NM|30973-2^dose number in series^LN|1|1|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|3|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J.||^Rodriguez^J.^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20190415|20190415|08^Hepatitis B^CVX^58160-0820-43^ENGERIX-B^NDC|0.5|mL^^UCUM||00^^NIP001|^Martinez^J.|^^^OP^^^^^4253 Standish Way^^Stamford^CT^06903||||6352FK2|20201001|SKB^GlaxoSmithKline Biologicals SA^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|RT^Right Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|45^hepatitis B vaccine, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||201904150515
OBX|3|NM|30973-2^dose number in series^LN|1|2|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|3|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J.||^Rodriguez^J.^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20190515|20190515|106^DTaP^CVX^49281-0286-58^DAPTACEL^NDC|0.5|mL^^UCUM||00^^NIP001|^Martinez^J.|^^^OP^^^^^4253 Standish Way^^Stamford^CT^06903||||D409QS2342|20201130|PMC^Sanofi Pasteur Inc^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LT^Left Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|107^diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20190515
OBX|3|NM|30973-2^dose number in series^LN|1|1|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|5|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J.||^Rodriguez^J.^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20190713|20190713|106^DTaP^CVX^49281-0286-58^DAPTACEL^NDC|0.5|mL^^UCUM||00^^NIP001|^Martinez^J.|^^^OP^^^^^4253 Standish Way^^Stamford^CT^06903||||D409QS2434|20190904|PMC^Sanofi Pasteur Inc^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LT^Left Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|107^diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20190713
OBX|3|NM|30973-2^dose number in series^LN|1|2|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|5|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J.||^Rodriguez^J.^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20190916|20190916|106^DTaP^CVX^49281-0286-58^DAPTACEL^NDC|0.5|mL^^UCUM||00^^NIP001|^Martinez^J.|^^^OP^^^^^4253 Standish Way^^Stamford^CT^06903||||D409QS3256|20191201|PMC^Sanofi Pasteur Inc^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LD^Left Deltoid^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|107^diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20190916
OBX|3|NM|30973-2^dose number in series^LN|1|3|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|5|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J.||^Rodriguez^J.^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20200820|20200820|106^DTaP^CVX^49281-0286-58^DAPTACEL^NDC|0.5|mL^^UCUM||00^^NIP001|^Martinez^J.|^^^OP^^^^^4253 Standish Way^^Stamford^CT^06903||||D409QS250|20210301|PMC^Sanofi Pasteur Inc^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LD^Left Deltoid^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|107^diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20200820
OBX|3|NM|30973-2^dose number in series^LN|1|4|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|5|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J.||^Rodriguez^J.^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20190514|20190514|49^Hib^CVX^00006-4897-01^PedvaxHIB^NDC|0.5|mL^^UCUM||00^^NIP001|^Martinez^J.|^^^OP^^^^^4253 Standish Way^^Stamford^CT^06903||||7M54K9255|20200324|MSD^Merck Sharp and Dohme Corp.^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|RT^Right Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|17^Hib, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20190514
OBX|3|NM|30973-2^dose number in series^LN|1|1|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|4|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J.||^Rodriguez^J.^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20190721|20190721|49^Hib^CVX^00006-4897-01^PedvaxHIB^NDC|0.5|mL^^UCUM||00^^NIP001|^Martinez^J.|^^^OP^^^^^4253 Standish Way^^Stamford^CT^06903||||7M55K3343|20191030|MSD^Merck Sharp and Dohme Corp.^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LT^Left Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|17^Hib, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20190721
OBX|3|NM|30973-2^dose number in series^LN|1|2|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|4|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J.||^Rodriguez^J.^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20190927|20190927|49^Hib^CVX^00006-4897-01^PedvaxHIB^NDC|0.5|mL^^UCUM||00^^NIP001|^Martinez^J.|^^^OP^^^^^4253 Standish Way^^Stamford^CT^06903||||7M75K4577|20200523|MSD^Merck Sharp and Dohme Corp.^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|RT^Right Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|17^Hib, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20190927
OBX|3|NM|30973-2^dose number in series^LN|1|3|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|4|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J.||^Rodriguez^J.^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20200504|20200504|49^Hib^CVX^00006-4897-01^PedvaxHIB^NDC|0.5|mL^^UCUM||00^^NIP001|^Martinez^J.|^^^OP^^^^^4253 Standish Way^^Stamford^CT^06903||||7M53K5535|20201014|MSD^Merck Sharp and Dohme Corp.^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LD^Left Deltoid^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|17^Hib, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20200504
OBX|3|NM|30973-2^dose number in series^LN|1|4|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|4|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J.||^Rodriguez^J.^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20190514|20190514|10^Polio (IPV)^CVX^49281-0860-88^IPOL^NDC|0.5|mL^^UCUM||00^^NIP001|^Martinez^J.|^^^OP^^^^^4253 Standish Way^^Stamford^CT^06903||||D333PV2444|20191004|PMC^MSanofi Pasteur Inc.^MVX|||CP|A
RXR|C38299^Subcutaneous^NCIT^SC^Subcutaneous^HL70162|LD^Left Deltoid^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|10^poliovirus vaccine, inactivated^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20190514
OBX|3|NM|30973-2^dose number in series^LN|1|1|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|4|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J.||^Rodriguez^J.^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20190721|20190721|10^Polio (IPV)^CVX^49281-0860-88^IPOL^NDC|0.5|mL^^UCUM||00^^NIP001|^Martinez^J.|^^^OP^^^^^4253 Standish Way^^Stamford^CT^06903||||D333PV4343|20200323|PMC^MSanofi Pasteur Inc.^MVX|||CP|A
RXR|C38299^Subcutaneous^NCIT^SC^Subcutaneous^HL70162|LD^Left Deltoid^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|10^poliovirus vaccine, inactivated^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20190721
OBX|3|NM|30973-2^dose number in series^LN|1|2|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|4|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J.||^Rodriguez^J.^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20191015|20191015|10^Polio (IPV)^CVX^49281-0860-88^IPOL^NDC|0.5|mL^^UCUM||00^^NIP001|^Martinez^J.|^^^OP^^^^^4253 Standish Way^^Stamford^CT^06903||||D333PV9654|20200222|PMC^MSanofi Pasteur Inc.^MVX|||CP|A
RXR|C38299^Subcutaneous^NCIT^SC^Subcutaneous^HL70162|LD^Left Deltoid^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|109^pneumococcal, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20191015
OBX|3|NM|30973-2^dose number in series^LN|1|3|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|4|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J.||^Rodriguez^J.^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20190518|20190518|133^Pneumococcal conjugate (PCV13)^CVX^00005-1971-01^PREVNAR 13^NDC|0.5|mL^^UCUM||00^^NIP001|^Martinez^J.|^^^OP^^^^^4253 Standish Way^^Stamford^CT^06903||||P243V3321|20200130|PFR^Pfizer, Inc^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LT^Left Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|109^pneumococcal, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20190518
OBX|3|NM|30973-2^dose number in series^LN|1|1|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|4|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J.||^Rodriguez^J.^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20190721|20190721|133^Pneumococcal conjugate (PCV13)^CVX^00005-1971-01^PREVNAR 13^NDC|0.5|mL^^UCUM||00^^NIP001|^Martinez^J.|^^^OP^^^^^4253 Standish Way^^Stamford^CT^06903||||P343V8445|20200330|PFR^Pfizer, Inc^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LT^Left Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|109^pneumococcal, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20180721
OBX|3|NM|30973-2^dose number in series^LN|1|2|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|4|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J.||^Rodriguez^J.^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20190927|20190927|133^Pneumococcal conjugate (PCV13)^CVX^00005-1971-01^PREVNAR 13^NDC|0.5|mL^^UCUM||00^^NIP001|^Martinez^J.|^^^OP^^^^^4253 Standish Way^^Stamford^CT^06903||||P853V2175|20200830|PFR^Pfizer, Inc^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|RT^Right Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|109^pneumococcal, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20190927
OBX|3|NM|30973-2^dose number in series^LN|1|3|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|4|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J.||^Rodriguez^J.^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20200504|20200504|133^Pneumococcal conjugate (PCV13)^CVX^00005-1971-01^PREVNAR 13^NDC|0.5|mL^^UCUM||00^^NIP001|^Martinez^J.|^^^OP^^^^^4253 Standish Way^^Stamford^CT^06903||||P853V58544|20201018|PFR^Pfizer, Inc^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LD^Left Deltoid^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|109^pneumococcal, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20200504
OBX|3|NM|30973-2^dose number in series^LN|1|4|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|4|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J.||^Rodriguez^J.^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20190518|20190518|119^Rotavirus^CVX^58160-0851-01^ROTARIX^NDC|1.0|mL^^UCUM||00^^NIP001|^Martinez^J.|^^^OP^^^^^4253 Standish Way^^Stamford^CT^06903||||6359RV543|20191029|SKB^GlaxoSmithKline Biologicals SA^MVX|||CP|A
RXR|C38288^Oral^NCIT^PO^Oral^HL70162|||||
OBX|1|CE|30956-7^vaccine type^LN|1|122^rotavirus, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20190518
OBX|3|NM|30973-2^dose number in series^LN|1|1|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|3|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J.||^Rodriguez^J.^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20190921|20190921|119^Rotavirus^CVX^58160-0851-01^ROTARIX^NDC|1.0|mL^^UCUM||00^^NIP001|^Martinez^J.|^^^OP^^^^^4253 Standish Way^^Stamford^CT^06903||||6359RV933|20200510|SKB^GlaxoSmithKline Biologicals SA^MVX|||CP|A
RXR|C38288^Oral^NCIT^PO^Oral^HL70162|||||
OBX|1|CE|30956-7^vaccine type^LN|1|122^rotavirus, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20190921
OBX|3|NM|30973-2^dose number in series^LN|1|2|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|3|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J.||^Rodriguez^J.^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20190927|20190927|161^Influenza^CVX^49281-0519-00^FLUZONE QUADRIVALENT^NDC|0.25|mL^^UCUM||00^^NIP001|^Martinez^J.|^^^OP^^^^^4253 Standish Way^^Stamford^CT^06903||||D8043IN8738|20200312|PMC^Sanofi Pasteur^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|LT^Left Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|88^influenza, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20190927
OBX|3|NM|30973-2^dose number in series^LN|1|1|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|2|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J.||^Rodriguez^J.^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20191020|20191020|161^Influenza^CVX^49281-0519-00^FLUZONE QUADRIVALENT^NDC|0.25|mL^^UCUM||00^^NIP001|^Martinez^J.|^^^OP^^^^^4253 Standish Way^^Stamford^CT^06903||||D8043IN8798|20200522|PMC^Sanofi Pasteur^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT^IM^Intramuscular^HL70162|RT^Right Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|88^influenza, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20191020
OBX|3|NM|30973-2^dose number in series^LN|1|2|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|2|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||197029^OP|||||||^Martinez^J.||^Rodriguez^J.^^^^^^^L^^^^^^^^^^^MD|||||OP^Oceanview Pediatrics^HL70362||||||||||||||
RXA|0|1|20200620|20200620|03^measles, mumps, rubella virus vaccine^CVX^00006-4681-01^MMR II^NDC|0.5|mL^^UCUM||00^^NIP001|^Martinez^J.|^^^OP^^^^^4253 Standish Way^^Stamford^CT^06903||||7W27V7632|20211215|MSD^Merck Sharp and Dohme Corp.^MVX|||CP|A
RXR|C38299^Subcutaneous^NCIT^SC^Subcutaneous^HL70162|LT^Left Thigh^HL70163||||
OBX|1|CE|30956-7^vaccine type^LN|1|03^MMR^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20200620
OBX|3|NM|30973-2^dose number in series^LN|1|1|NA^^HL70353|||||F
OBX|4|NM|59782-3^number of doses in series^LN|1|2|NA^^HL70353|||||F
OBX|5|ID|59781-5^Dose validity^LN|1|Y||||||F
ORC|RE||9999^OP|||||||^Clerk^Myron|||||||STIIS^StateIIS^HL70362
RXA|0|1|20201031|20201031|998^no vaccine admin^CVX|999||| |||||||||||NA
OBX|1|CE|30956-7^vaccine type^LN|1|45^Hep B, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20201031
OBX|3|DT|30981-5^Earliest date to give^LN|1|20200904||||||F
OBX|4|DT|30980-7^Date vaccination due^LN|1|20200904||||||F
OBX|5|DT|59778-1^Date dose is overdue^LN|1|20201004||||||F
OBX|6|NM|30973-2^dose number in series^LN|1|3|NA^^HL70353|||||F|||20201031
ORC|RE||9999^OP|||||||^Clerk^Myron|||||||STIIS^StateIIS^HL70362
RXA|0|1|20201031|20201031|998^no vaccine admin^CVX|999||| |||||||||||NA
OBX|1|CE|30956-7^vaccine type^LN|1|88^influenza, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20201031
OBX|3|DT|30980-7^Date vaccination due^LN|1|20200904||||||F
ORC|RE||9999^OP|||||||^Clerk^Myron|||||||STIIS^StateIIS^HL70362
RXA|0|1|20201031|20201031|998^no vaccine admin^CVX|999||| |||||||||||NA
OBX|1|CE|30956-7^vaccine type^LN|1|21^Varicella^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20201031
OBX|3|DT|30981-5^Earliest date to give^LN|1|20200304||||||F
OBX|4|DT|30980-7^Date vaccination due^LN|1|20200304||||||F
ORC|RE||9999^OP|||||||^Clerk^Myron|||||||STIIS^StateIIS^HL70362
RXA|0|1|20201031|20201031|998^no vaccine admin^CVX|999||| |||||||||||NA
OBX|1|CE|30956-7^vaccine type^LN|1|85^Hep A, pediatric, unspecified formulation^CVX||||||F
OBX|2|CE|59779-9^Immunization Schedule used^LN|1|VXC16^ACIP^CDCPHINVS||||||F|||20201031
OBX|3|DT|30981-5^Earliest date to give^LN|1|20200304||||||F
OBX|4|DT|30980-7^Date vaccination due^LN|1|20200304||||||F